Home LiteratureArticle Details
PMID: 10605005 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression.

Journal of immunology (Baltimore, Md. : 1950) ·Vol. 164 ·No. 1 ·2000-01-01 ·Pages 144-51

Appleman LJ, Berezovskaya A, Grass I, Boussiotis VA

Abstract

In the presence of TCR ligation by Ag, CD28 pathway mediates the most potent costimulatory signal for T cell activation, cytokine secretion, and T cell expansion. Although CD28 costimulation promotes T cell expansion due to IL-2 secretion and subsequent signaling via the IL-2 receptor, recent studies indicate that the dramatic T cell expansion mediated through the unopposed CD28 stimulation in CTLA4-deficient mice is IL-2 independent. Therefore, we sought to dissect the effects of CD28 and IL-2 receptor pathways on cell cycle progression and determine the molecular mechanisms by which the CD28 pathway regulates T cell expansion. Here we show that CD28 costimulation directly regulates T cell cycle entry and progression through the G1 phase in an IL-2-independent manner resulting in activation of cyclin D2-associated cdk4/cdk6 and cyclin E-associated cdk2. Subsequent progression into the S phase is mediated via both IL-2-dependent and IL-2-independent mechanisms and, although in the absence of IL-2 the majority of T cells are arrested at the G1/S transition, a significant fraction of them progresses into the S phase. The key regulatory mechanism for the activation of cyclin-cdk complexes and cell cycle progression is the down-regulation of p27kip1 cdk inhibitor, which is mediated at the posttranscriptional level by its ubiquitin-dependent degradation in the proteasome pathway. Therefore, CD28 costimulation mediates T cell expansion in an IL-2-independent and IL-2 dependent manner and regulates cell cycle progression at two distinct points: at the early G1 phase and at the G1/S transition.

MeSH Terms
CD28 Antigens/physiology Cell Cycle/immunology Cell Cycle Proteins Cells, Cultured Cyclin-Dependent Kinase Inhibitor p27 Cyclin-Dependent Kinases/antagonists & inhibitors Cysteine Endopeptidases/metabolism Down-Regulation/genetics,immunology Enzyme Inhibitors/metabolism,pharmacology G1 Phase/immunology Humans Interleukin-2/physiology Lymphocyte Activation Microtubule-Associated Proteins/antagonists & inhibitors,biosynthesis,genetics,physiology Multienzyme Complexes/metabolism Phosphorylation Proteasome Endopeptidase Complex Protein Processing, Post-Translational/genetics,immunology Retinoblastoma Protein/metabolism S Phase/immunology Signal Transduction/genetics,immunology T-Lymphocytes/cytology,enzymology,immunology,metabolism Tumor Suppressor Proteins Ubiquitins/metabolism
Chemicals
CD28 Antigens Cell Cycle Proteins Enzyme Inhibitors Interleukin-2 Microtubule-Associated Proteins Multienzyme Complexes Retinoblastoma Protein Tumor Suppressor Proteins Ubiquitins Cyclin-Dependent Kinase Inhibitor p27 Cyclin-Dependent Kinases Cysteine Endopeptidases Proteasome Endopeptidase Complex
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Appleman L J
Department of Adult Oncology, Dana-Farber Cancer Institute, Division of Medical Oncology, Brigham and Women's Hospital, Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.
Berezovskaya A
Grass I
Boussiotis V A
Article Info
Journal
Journal of immunology (Baltimore, Md. : 1950)
Abbr.
J Immunol
ISSN
0022-1767
Published
2000-01-01
Pages
144-51
Language
English
Region
United States
NLM ID
2985117R
Subset
IM
Grants
NIAID NIH HHS · AI 41584 · United States
NIAID NIH HHS · AI 43552 · United States
NHLBI NIH HHS · HL 54785 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com